Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free ...

A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new ...

Dec. 2, 2024 — In June of 2024, the Endocrine Society, influenced by a substantial body of research conducted in recent years, published new clinical practice guidelines for the testing and ...

Dec. 2, 2024 — In June of 2024, the Endocrine Society, influenced by a substantial body of research conducted in recent years, published new clinical practice guidelines for the testing and ...

CDK4/6 inhibitors have shown tremendous improvements in outcomes for women diagnosed with advanced breast cancer when used in conjunction with endocrine ... the healthcare system, with cost ...

1 This endocrine-related adaptation to pregnancy ... it then activates the receptor activator of nuclear factor κB ligand (RANKL) system, which stimulates osteoclastic bone resorption and ...

Get your mind on your team. Learn how to break free from negative thought patterns in just two seconds, rewiring your brain ...

Differences were compared between individuals exposed to H. pylori vs. those not exposed and between those positive or negative for PCA, focusing on the incidence of gastric adenocarcinoma and type 1 ...

One in four women who have given birth in the UK have reported a negative experience ... secretary to take urgent action to fix a "broken" system. Research carried out by campaign group Delivering ...

negative (ER+/HER2-) breast cancer. Vepdegestrant is being developed as a potential monotherapy and as part of combination therapy across multiple treatment settings for ER+/HER2- metastatic ...